Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Eli Lilly and Company, 3 years.
Eli Lilly and Company
Director
Archer-Daniels-Midland Company
Director ยท President & CEO
Chief executive roles
Archer-Daniels-Midland Company
ยท President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2025 | Eli Lilly and Company | Grant or award | +20 | $748.19 | $14,837 |
| Aug 18, 2025 | Eli Lilly and Company | Grant or award | +21 | $698.05 | $14,834 |
| Jun 16, 2025 | Eli Lilly and Company | Grant or award | +18 | $807.58 | $14,835 |
| May 19, 2025 | Eli Lilly and Company | Grant or award | +20 | $755.11 | $14,830 |
| Apr 21, 2025 | Eli Lilly and Company | Grant or award | +18 | $818.02 | $14,831 |
| Mar 20, 2025 | Archer-Daniels-Midland Company | Shares withheld for tax | โ17,394 | $46.93 | $816,300 |
| Mar 17, 2025 | Eli Lilly and Company | Grant or award | +18 | $824.76 | $14,837 |
| Feb 18, 2025 | Eli Lilly and Company | Grant or award | +17 | $857.20 | $14,830 |
| Feb 13, 2025 | Archer-Daniels-Midland Company | Grant or award | +154,890 | โ | โ |
| Feb 10, 2025 | Archer-Daniels-Midland Company | Shares withheld for tax | โ12,897 | $45.76 | $590,167 |
| Feb 10, 2025 | Archer-Daniels-Midland Company | Shares withheld for tax | โ34,145 | $45.76 | $1,562,475 |
| Feb 10, 2025 | Archer-Daniels-Midland Company | Shares withheld for tax | โ40,648 | $45.76 | $1,860,052 |
| Feb 7, 2025 | Archer-Daniels-Midland Company | Grant or award | +77,076 | โ | โ |
| Jan 21, 2025 | Eli Lilly and Company | Grant or award | +20 | $742.35 | $14,832 |
| Dec 16, 2024 | Eli Lilly and Company | Grant or award | +19 | $779.00 | $14,832 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.